Posted by Michael Wonder on 28 Dec 2020
PBS listings bring greater hope in fight against multiple myeloma and severe psoriasis
28 December 2020 - Critical new medicines have been listed on the Pharmaceutical Benefits Scheme, including to fight one of the most common blood cancers.
From 1 January 2021, Darzalex (daratumumab) will be listed for the first time in combination with bortezomib and dexamethasone, as a second-line treatment for patients with multiple myeloma – a cancer of the plasma cells.
Also from 1 January 2021, Australians living with severe chronic psoriasis will benefit from the first time listing of Otezla (apremilast) on the PBS.
